The Advisory Committee on Immunization Practices is hearing updates from Centers for Disease Control and Prevention officials on reports of J&J vaccine recipients experiencing blood clots combined with low blood-platelet levels.

The committee is expected to vote Thursday afternoon on whether to update its recommendation on use of the J&J vaccine, according to an agenda posted online by the CDC.

CDC Advisers Review Blood-Clotting Risk Associated With J&J’s Covid-19 Vaccine – WSJ